RXO Inc
NYSE:RXO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
18.91
31.9
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Wall Street
Price Targets
RXO Price Targets Summary
RXO Inc
According to Wall Street analysts, the average 1-year price target for RXO is 28.26 USD with a low forecast of 12.12 USD and a high forecast of 34.65 USD.
RXO Last Price Targets
RXO Inc
The latest public price target was made on Nov 18, 2024 by
Jordan Alliger
from
Goldman Sachs
,
who expects
RXO
stock to
rise by 21%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Jordan Alliger
Goldman Sachs
|
29
USD
Upside 21% |
1 month ago
Nov 18, 2024
|
Goldman Sachs Reinstates RXO, Inc. (RXO) at Neutral
StreetInsider
|
Ariel Rosa
Citigroup
|
33
USD
Upside 38% |
2 months ago
Oct 8, 2024
|
RXO Inc. initiated with a Buy at Citi
TheFly
|
Bascome Majors
Susquehanna
|
16
USD
Downside 33% |
3 months ago
Sep 26, 2024
|
RXO Inc. price target lowered to $16 from $20 at Susquehanna
TheFly
|
Scott Schneeberger
Oppenheimer
|
31
USD
Upside 29% |
3 months ago
Sep 17, 2024
|
Oppenheimer Reiterates Outperform Rating on RXO, Inc. (RXO)
StreetInsider
|
Stephanie Moore
Jefferies
|
31
USD
Upside 29% |
3 months ago
Sep 11, 2024
|
Jefferies Reiterates Buy Rating on RXO, Inc. (RXO)
StreetInsider
|
|
Daniel Imbro
Stephens
|
25
USD
Upside 4% |
5 months ago
Jul 8, 2024
|
RXO Inc. price target raised to $25 from $22 at Stephens
TheFly
|
Bruce Chen
Stifel Nicolaus
|
26
USD
Upside 8% |
6 months ago
Jun 25, 2024
|
RXO, Inc. (RXO) PT Raised to $26 at Stifel
StreetInsider
|
|
Stephanie Moore
Jefferies
|
30
USD
Upside 25% |
6 months ago
Jun 24, 2024
|
RXO, Inc. (RXO) PT Raised to $30 at Jefferies
StreetInsider
|
Tom Wadewitz
UBS
|
22
USD
Downside 8% |
6 months ago
Jun 20, 2024
|
UBS Reiterates Neutral Rating on RXO, Inc. (RXO)
StreetInsider
|
Scott Group
Wolfe Research
|
15
USD
Downside 37% |
8 months ago
Apr 11, 2024
|
RXO Inc. price target lowered to $15 from $16 at Wolfe Research
TheFly
|
|
Bascome Majors
Susquehanna
|
20
USD
Downside 17% |
1 year ago
Jun 9, 2023
|
Evaluating RXO's Potential: Analyst Highlights Company's Robust Balance Sheet and FCF Conversion Rate
Benzinga
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is RXO's stock price target?
Price Target
28.26
USD
According to Wall Street analysts, the average 1-year price target for RXO is 28.26 USD with a low forecast of 12.12 USD and a high forecast of 34.65 USD.
What is RXO Inc's Revenue forecast?
Projected CAGR
21%
For the last 3 years the compound annual growth rate for RXO Inc's revenue is 5%. The projected CAGR for the next 4 years is 21%.
What is RXO Inc's Operating Income forecast?
Projected CAGR
46%
For the last 3 years the compound annual growth rate for RXO Inc's operating income is -7%. The projected CAGR for the next 4 years is 46%.
What is RXO Inc's Net Income forecast?
Projected CAGR
167%
For the last 3 years the compound annual growth rate for RXO Inc's net income is -55%. The projected CAGR for the next 4 years is 167%.
You don't have any saved screeners yet
